Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TRIENTINE HYDROCHLORIDE
- Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).
- The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
- Copper Concentration and Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840
- Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
- Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
- A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
- A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients
- Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
- Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus
- Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
- Trientine and Carboplatin in Advanced Malignancies
- Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
- Study of Tetrathiomolybdate in Patients With Wilson Disease
Clinical trials list
click for details